Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
APGAR ScoreAssisted Delivery (FIGO)BPP (Manning Score)Bishop ScoreCARPREG II Cardiac RiskCervical Cancer StagingContraceptive Pearl IndexDoppler Matrix (UA/MCA)EFW (Hadlock)Endometrial StagingEndometrial ThicknessFGR Criteria (Consensus)FSFI (Sexual Function)Ferriman-Gallwey ScoreFetal Anemia (MCA PSV)GDM Diagnostic CriteriaGPA History IndicatorGail Model Breast RiskGestational Dating (LMP)HIV PMTCT ProtocolIOTA Simple RulesIVF Due Date & AMHIron Deficit (Ganzoni)Labour Progress (WHO)Maternal Sepsis (qSOFA)O-RADS ClassificationOvarian Cancer StagingPAS Hemorrhage RiskPPH Protocol (FIGO)Preeclampsia (ACOG)Rho(D) Dose (K-B)Rotterdam PCOS CriteriaSyphilis ManagementTORCH FrameworkVBAC Success ProbabilityVulvar Cancer StagingWeight Gain (IOM)mWHO Cardiac Risk
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

Drug SafetyJun 2, 2026
Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study

Clinical Context

We think this might be relevant to the clinical guidance for Syphilis Management in Pregnancy.

JAMAJun 2, 2026
Syphilis Linked to Higher Risk of Some Cardiovascular Outcomes

Clinical Context

We think this might be relevant to the clinical guidance for Syphilis Management in Pregnancy.

JAMAJun 2, 2026
New Study Finds No Link Between Acetaminophen Use in Pregnancy and Autism

Clinical Context

We think this might be relevant to the clinical guidance for Syphilis Management in Pregnancy.

Syphilis Management

Syphilis in Pregnancy

Screening Protocol
  • Universal Screening at 1st ANC
  • RPR / VDRL (Non-treponemal)
  • TPPA / TPHA (Treponemal Confirm)
  • Repeat at 28w & Delivery in high-risk
WHO/FIGO Treatment

Benzathine Penicillin G

2.4 Million Units (MU) IM

Congenital Prevention

Goal: Treatment > 30 Days before EDD

Jarisch-Herxheimer reaction risk: Warn patient & monitored especially in late pregnancy due to potential for uterine contractions and fetal distress.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Screen

Universal screening at the first prenatal visit (required by law in most jurisdictions).
Rescreen at 28 weeks and at delivery for high-risk patients or those in high-prevalence areas.
Evaluation of any patient presenting with an unexplained maculopapular rash (palms/soles) or painless genital ulcer (chancre).
Mandatory workup for all cases of fetal hydrops or unexplained stillbirth.

Diagnosis Requirements

Diagnosis requires two-stage serologic testing: a nontreponemal test (RPR or VDRL) and a treponemal-specific test (TP-PA or FTA-ABS). A single positive test is insufficient due to potential biological false positives.

Last Comprehensive Review: 2026